Cerebrovascular and Alzheimer disease: fellow travelers or partners in crime?
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
In this review, we will discuss the progressive decline in cognitive and intellectual performance in late life that has led to great challenges for medical and community services. The term ‘vascular cognitive impairment’ is defined as any cognitive impairment that is caused by or associated with vascular factors. It can occur alone or in association with Alzheimer disease. The good news is that because vascular risk factors are treatable, it should be possible to prevent or delay some dementias. Since vascular cognitive impairment may often go unrecognized, many experts recommend screening with brief tests to assess memory, thinking, and reasoning for everyone considered to be at high risk for this disorder. Up to 64% of persons 65 years or older who have experienced a stroke have some degree of cognitive impairment with up to one third developing dementia. Postmortem studies indicate that up to 34% of dementia cases show significant vascular pathology. It suggests that ischemic stroke triggers additional pathophysiological process that may lead to a secondary degenerative process that may interact with Alzheimer disease pathology thus accelerating the ongoing primary neurodegeneration. Mechanisms could include hypoperfusion, hypoxia, and neuroinflammation, one of the links between the two pathologies. Stroke and dementia share the same risk and protective factors. Since stroke interact with dementia of all types it may already be possible to reduce or delay some dementias by a number of interventions known to prevent stroke. image This article is part of the Special Issue “Vascular Dementia”.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Pendlebury, S. T., & Rothwell, P. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70236-4 · Cited by 1,853
Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke · doi:10.1161/01.str.0000237236.88823.47 · Cited by 1,722 · cited 5×
“The term ‘vascular cognitive impairment’ (VCI) was defined as any cognitive impairment that is caused by or associated with vascular factors (Hachinski 1994).”
InfluentialSelf-citationMediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial
Valls-Pedret, C., Sala-Vila, A., Serra-Mir, M., Corella, D., de la Torre, R., Martínez-González, M. Á., Martínez-Lapiscina, E. H., Fitó, M., Pérez-Heras, A., Salas-Salvadó, J., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.1668 · Cited by 952
Trajectory of Cognitive Decline After Incident Stroke
Levine, D. A., Galecki, A. T., Langa, K. M., Unverzagt, F. W., Kabeto, M. U., Giordani, B., & Wadley, V. G. (2015) · JAMA · doi:10.1001/jama.2015.6968 · Cited by 497
Less dementia with oral anticoagulation in atrial fibrillation
Friberg, L., & Rosenqvist, M. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx579 · Cited by 279 · cited 2×
“The association of atrial fibrillation with stroke risk has been long established, recently a study showed that up to a 48% reduction of dementia risk on patients with atrial fibrillation are anticoagulated compared to patients who are not (Friberg and Rosenqvist 2017).”
Epidemiological Studies of the Effect of Stroke on Incident Dementia: A Systematic Review
Savva, G. M., Stephan, B. C. M., & the Alzheimer’s Society Vascular Dementia Systematic Review Group (2010) · Stroke · doi:10.1161/strokeaha.109.559880 · Cited by 257
Stroke and Potentially Preventable Dementias Proclamation: Updated World Stroke Day Proclamation
Hachinski, V. (2015) · Stroke · doi:10.1161/strokeaha.115.011237 · Cited by 71 · cited 5×
“The term ‘vascular cognitive impairment’ (VCI) was defined as any cognitive impairment that is caused by or associated with vascular factors (Hachinski 1994).”
InfluentialSelf-citationPopulation‐based stroke and dementia incidence trends: Age and sex variations
Cerasuolo, J. O., Cipriano, L. E., Sposato, L. A., Kapral, M. K., Fang, J., Gill, S. S., Hackam, D. G., & Hachinski, V. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.02.010 · Cited by 59
Self-citation
Cited by
Calderón-Garcidueñas, L., González-Maciel, A., Reynoso-Robles, R., Kulesza, R. J., Mukherjee, P. S., Torres-Jardón, R., Rönkkö, T., & Doty, R. L. (2018) · Environmental Research · doi:10.1016/j.envres.2018.06.027 · Cited by 110
The puzzle of sex, gender and Alzheimer’s disease: Why are women more often affected than men?
Andrew, M. K., & Tierney, M. C. (2018) · Women's Health · doi:10.1177/1745506518817995 · Cited by 75
Tang, A. S., Oskotsky, T., Havaldar, S., Mantyh, W. G., Bicak, M., Solsberg, C. W., Woldemariam, S., Zeng, B., Hu, Z., Oskotsky, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28273-0 · Cited by 45
“Prior work, largely hypothesis-driven, focused on select comorbidities associated with AD, such as hypertension 16 , vascular disorders 17 , diabetes 18 , obesity 19 , and others 20 – 22 .”
Metadata
- Authors
- Nucera, A., & Hachinski, V.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2018-01-25
- Volume
- 144
- Issue
- 5
- Pages
- 513-516
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2779544674
- Cited by
- 41
- References
- 10
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.